Market report
Pharmaceutical tenders in Czechia — market report, March 2026
Pharmaceutical tenders in Czechia in March 2026: 9,679 tenders published (+13% month on month, 0% year on year), estimated at €844,673,398 in total, and 9,848 contracts awarded (+15% month on month, +1% year on year), worth €102,682,693 (awarded value). Buyers with the most tenders: Fakultní nemocnice Brno (888), Fakultní nemocnice Bulovka (851) and Institut klinické a experimentální medicíny (810); most contracts won: ViaPharma s.r.o. (217), Janssen-Cilag s.r.o. (189) and AbbVie s.r.o. (188). On average 14.9 bids per contract; 45% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 9,679
- Contracts awarded
- 9,848
- Contract value awarded
- €102,682,693
- Bids per contract
- 14.9
The highlighted bar is March 2026. Hover a bar for its figure; the table below has every value.
| Figure | March 2026 | February 2026 | Change | March 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 9,679 | 8,564 | +13% | 9,718 | 0% |
| Estimated value | €844,673,398 | €20,580,465 | +4,004% | €89,662,498 | +842% |
| Buyers | 89 | 79 | +13% | 92 | -3% |
| Contracts awarded | 9,848 | 8,589 | +15% | 9,772 | +1% |
| Contract value (awarded) | €102,682,693 | €65,148,878 | +58% | €86,428,865 | +19% |
| Winners | 434 | 395 | +10% | 383 | +13% |
| Bids per contract | 14.9 | 4.3 | — | 14.6 | — |
| Single-bid contracts | 45% | 52% | — | 50% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 217 |
| 2 | Janssen-Cilag s.r.o. | 189 |
| 3 | AbbVie s.r.o. | 188 |
| 4 | Takeda Pharmaceuticals Czech Republic s.r.o. | 166 |
| 5 | ROCHE s.r.o. | 154 |
| 6 | Amgen s.r.o. | 138 |
| 7 | Avenier a.s. | 131 |
| 8 | Merck Sharp & Dohme s.r.o. | 122 |
| 9 | Johnson & Johnson, s.r.o. | 110 |
| 10 | ELI LILLY ČR, s.r.o. | 107 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in March 2026?
- 9,679 (by 89 buyers); for comparison, February 2026: 8,564, March 2025: 9,718.
- Who won the most pharmaceutical tenders in Czechia in March 2026?
- By number of contracts: ViaPharma s.r.o. (217), Janssen-Cilag s.r.o. (189), AbbVie s.r.o. (188), Takeda Pharmaceuticals Czech Republic s.r.o. (166) and ROCHE s.r.o. (154); 434 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in March 2026?
- Fakultní nemocnice Brno (888), Fakultní nemocnice Bulovka (851), Institut klinické a experimentální medicíny (810), Krajská zdravotní, a.s. (796) and Fakultní nemocnice Olomouc (790).
- How competitive were pharmaceutical tenders in Czechia in March 2026?
- On average 14.9 bids per contract (258 contracts with a known number of bids); 45% of contracts had a single bid.
- What were the contracts worth in March 2026?
- €102,682,693 (awarded value, 9,848 contracts); median about €150,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.